Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
18,84 USD | +2,89 % | +2,84 % | -19,31 % |
Métier
Nombre d'employés: 59
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jonathan Young
FOU | Founder | 54 | 01/04/17 |
Timothy Rolph
FOU | Founder | 70 | 01/04/17 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01/09/18 |
William White
DFI | Director of Finance/CFO | 51 | 01/04/19 |
Chief Tech/Sci/R&D Officer | - | 01/12/20 | |
Investor Relations Contact | - | - | |
Libette Luce
LAW | General Counsel | - | 01/05/22 |
Patrick Lamy
PRN | Corporate Officer/Principal | 51 | 01/01/23 |
Kitty Yale
PRN | Corporate Officer/Principal | 52 | 01/10/18 |
Arindam Bose
PRN | Corporate Officer/Principal | 71 | 01/01/19 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Seth Harrison
BRD | Director/Board Member | 63 | 01/01/17 |
Jane Henderson
BRD | Director/Board Member | 58 | 23/04/19 |
Mark Iwicki
CHM | Chairman | 57 | 01/11/18 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01/09/18 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 09/06/20 |
Jonathan Young
FOU | Founder | 54 | 01/04/17 |
Judy Chou
BRD | Director/Board Member | 58 | 12/07/21 |
Graham Walmsley
BRD | Director/Board Member | 37 | 01/06/18 |
Yuan Xu
BRD | Director/Board Member | 56 | 22/04/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 69 151 007 | 58 768 380 ( 84,99 %) | 0 | 84,99 % |
Coordonnées société
Akero Therapeutics, Inc.
601 Gateway Boulevard Suite 350
94080-7006, South San Francisco
+650 487 6488
http://www.akerotx.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-19,31 % | 1,3 Md | |
+11,91 % | 118 Md | |
+11,60 % | 106 Md | |
-4,68 % | 24,28 Md | |
-0,82 % | 21,96 Md | |
-10,12 % | 18,16 Md | |
-42,12 % | 16,37 Md | |
-17,47 % | 15,56 Md | |
+2,77 % | 13,63 Md | |
+34,58 % | 12,27 Md |
- Bourse
- Actions
- Action AKRO
- Société Akero Therapeutics, Inc.